KR100722578B1 - 비오틴-결합 수용체 분자 - Google Patents
비오틴-결합 수용체 분자 Download PDFInfo
- Publication number
- KR100722578B1 KR100722578B1 KR1020007009270A KR20007009270A KR100722578B1 KR 100722578 B1 KR100722578 B1 KR 100722578B1 KR 1020007009270 A KR1020007009270 A KR 1020007009270A KR 20007009270 A KR20007009270 A KR 20007009270A KR 100722578 B1 KR100722578 B1 KR 100722578B1
- Authority
- KR
- South Korea
- Prior art keywords
- thr
- leu
- glu
- ser
- asn
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
- C12N5/12—Fused cells, e.g. hybridomas
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/465—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from birds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- General Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9803757.5 | 1998-02-23 | ||
| GBGB9803757.5A GB9803757D0 (en) | 1998-02-23 | 1998-02-23 | Fusion proteins |
| GB9813653.4 | 1998-06-24 | ||
| GBGB9813653.4A GB9813653D0 (en) | 1998-06-24 | 1998-06-24 | Fusion proteins |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR20010085196A KR20010085196A (ko) | 2001-09-07 |
| KR100722578B1 true KR100722578B1 (ko) | 2007-05-28 |
Family
ID=26313170
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020007009270A Expired - Fee Related KR100722578B1 (ko) | 1998-02-23 | 1999-02-23 | 비오틴-결합 수용체 분자 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US7208291B2 (https=) |
| EP (1) | EP1056850B1 (https=) |
| JP (1) | JP2002504328A (https=) |
| KR (1) | KR100722578B1 (https=) |
| CN (1) | CN1195852C (https=) |
| AT (1) | ATE274058T1 (https=) |
| AU (1) | AU750444B2 (https=) |
| CA (1) | CA2319039A1 (https=) |
| DE (1) | DE69919515T2 (https=) |
| DK (1) | DK1056850T3 (https=) |
| ES (1) | ES2226340T3 (https=) |
| HU (1) | HUP0101614A3 (https=) |
| NO (1) | NO328139B1 (https=) |
| PL (1) | PL195990B1 (https=) |
| PT (1) | PT1056850E (https=) |
| WO (1) | WO1999042577A2 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040209294A1 (en) * | 2002-09-02 | 2004-10-21 | National Food Research Institute | Method to produce a receptor chip using biotinylated protein |
| US9623117B2 (en) * | 2011-04-04 | 2017-04-18 | Wisconsin Alumni Research Foundation | Method for selective targeting and entry of bacterial toxins to cells |
| CN113354744A (zh) * | 2013-12-20 | 2021-09-07 | 弗雷德哈钦森癌症研究中心 | 带标签的嵌合效应分子及其受体 |
| EP3288570A4 (en) | 2015-04-29 | 2018-11-21 | Fred Hutchinson Cancer Research Center | Modified stem cells and uses thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1987005026A1 (en) * | 1986-02-24 | 1987-08-27 | The Trustees Of Columbia University In The City Of | Dna encoding streptavidin, streptavidin produced therefrom, fused polypeptides which include amino acid sequences present in streptavidin and uses thereof |
| WO1997019957A1 (en) * | 1995-11-30 | 1997-06-05 | New York University | High efficiency tissue specific compound delivery system using streptavidin-protein a fusion protein |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5135736A (en) * | 1988-08-15 | 1992-08-04 | Neorx Corporation | Covalently-linked complexes and methods for enhanced cytotoxicity and imaging |
| CA1340977C (en) | 1988-11-15 | 2000-04-25 | Monty Krieger | Scavenger receptor protein and antibody thereto |
| US5457035A (en) | 1993-07-23 | 1995-10-10 | Immunex Corporation | Cytokine which is a ligand for OX40 |
| US5846537A (en) | 1995-06-07 | 1998-12-08 | University Of Rochester | Modified avidin and streptavidin and methods of use thereof |
-
1999
- 1999-02-23 KR KR1020007009270A patent/KR100722578B1/ko not_active Expired - Fee Related
- 1999-02-23 HU HU0101614A patent/HUP0101614A3/hu not_active Application Discontinuation
- 1999-02-23 DE DE69919515T patent/DE69919515T2/de not_active Expired - Lifetime
- 1999-02-23 ES ES99906341T patent/ES2226340T3/es not_active Expired - Lifetime
- 1999-02-23 DK DK99906341T patent/DK1056850T3/da active
- 1999-02-23 AT AT99906341T patent/ATE274058T1/de not_active IP Right Cessation
- 1999-02-23 PL PL99343079A patent/PL195990B1/pl not_active IP Right Cessation
- 1999-02-23 CN CNB998032174A patent/CN1195852C/zh not_active Expired - Fee Related
- 1999-02-23 PT PT99906341T patent/PT1056850E/pt unknown
- 1999-02-23 AU AU26312/99A patent/AU750444B2/en not_active Ceased
- 1999-02-23 CA CA002319039A patent/CA2319039A1/en not_active Abandoned
- 1999-02-23 JP JP2000532517A patent/JP2002504328A/ja active Pending
- 1999-02-23 WO PCT/GB1999/000546 patent/WO1999042577A2/en not_active Ceased
- 1999-02-23 EP EP99906341A patent/EP1056850B1/en not_active Expired - Lifetime
-
2000
- 2000-08-22 NO NO20004195A patent/NO328139B1/no not_active IP Right Cessation
-
2003
- 2003-07-11 US US10/618,570 patent/US7208291B2/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1987005026A1 (en) * | 1986-02-24 | 1987-08-27 | The Trustees Of Columbia University In The City Of | Dna encoding streptavidin, streptavidin produced therefrom, fused polypeptides which include amino acid sequences present in streptavidin and uses thereof |
| WO1997019957A1 (en) * | 1995-11-30 | 1997-06-05 | New York University | High efficiency tissue specific compound delivery system using streptavidin-protein a fusion protein |
Non-Patent Citations (1)
| Title |
|---|
| FASEB J., vol.9(6), pp.A1395, 1995.4.24. * |
Also Published As
| Publication number | Publication date |
|---|---|
| DE69919515D1 (de) | 2004-09-23 |
| JP2002504328A (ja) | 2002-02-12 |
| US20040185059A1 (en) | 2004-09-23 |
| HUP0101614A2 (hu) | 2001-09-28 |
| WO1999042577A3 (en) | 1999-10-21 |
| CA2319039A1 (en) | 1999-08-26 |
| PL343079A1 (en) | 2001-07-30 |
| DK1056850T3 (da) | 2004-11-29 |
| PT1056850E (pt) | 2004-12-31 |
| NO328139B1 (no) | 2009-12-14 |
| DE69919515T2 (de) | 2005-04-07 |
| KR20010085196A (ko) | 2001-09-07 |
| PL195990B1 (pl) | 2007-11-30 |
| ES2226340T3 (es) | 2005-03-16 |
| AU2631299A (en) | 1999-09-06 |
| EP1056850A2 (en) | 2000-12-06 |
| US7208291B2 (en) | 2007-04-24 |
| AU750444B2 (en) | 2002-07-18 |
| NO20004195L (no) | 2000-08-22 |
| EP1056850B1 (en) | 2004-08-18 |
| CN1195852C (zh) | 2005-04-06 |
| ATE274058T1 (de) | 2004-09-15 |
| CN1291230A (zh) | 2001-04-11 |
| HUP0101614A3 (en) | 2006-04-28 |
| WO1999042577A2 (en) | 1999-08-26 |
| NO20004195D0 (no) | 2000-08-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1991560B1 (en) | Peptide having cell membrane penetrating activity | |
| US7638281B2 (en) | Polypeptide, cDNA encoding the same and use of them | |
| US7423139B2 (en) | High level expression of recombinant human erythropoietin having a modified 5′-UTR | |
| US20200246420A1 (en) | pHLIP® peptide-mediated epitope tethering at cell surfaces | |
| JP6574175B2 (ja) | 細胞透過性ペプチド、及びそれを含むコンジュゲート | |
| KR100629185B1 (ko) | 인간 리조포스파티드산 수용체 물질 및 그 용도 | |
| WO2008100122A1 (en) | Oligomerizaed protein transduction domains, a method for preparing the same and an intracellular transduction method using the same | |
| KR100722578B1 (ko) | 비오틴-결합 수용체 분자 | |
| US5925548A (en) | Modified receptors that continuously signal | |
| EP1163334A1 (en) | Polynucleotide and deduced amino acid sequences from stromal cells | |
| EP1363942A2 (de) | Polypeptide eines hdm2-protein spezifischen murinen alpha/beta t-zell rezeptors, diese kodierende nukleinsüren und deren verwendung | |
| JP2002504328A5 (https=) | ||
| MXPA00007931A (en) | Biotin-binding receptor molecules | |
| AU2018455720B2 (en) | Mutated human 2IG-B7-H3 protein coding gene, recombinant vector, host cell containing same, pharmaceutical composition and application thereof | |
| JP2003526323A (ja) | Kdel受容体インヒビター | |
| US8101736B2 (en) | Polynucleotides and polypeptide of human KV1.3, compositions comprising same and methods of using same | |
| ES2264564T3 (es) | Factor de crecimiento htter36. | |
| TW200902545A (en) | Compositions and methods of using CRMP-1 and its fragments for treating cancer | |
| CA2410525A1 (en) | Fas ligand-fused proteins | |
| AU773085B2 (en) | Transfer compounds, the production and the use thereof | |
| JPWO2000001405A1 (ja) | 軟骨細胞の分化促進剤 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
St.27 status event code: A-0-1-A10-A15-nap-PA0105 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| PG1501 | Laying open of application |
St.27 status event code: A-1-1-Q10-Q12-nap-PG1501 |
|
| R17-X000 | Change to representative recorded |
St.27 status event code: A-3-3-R10-R17-oth-X000 |
|
| A201 | Request for examination | ||
| E13-X000 | Pre-grant limitation requested |
St.27 status event code: A-2-3-E10-E13-lim-X000 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| PA0201 | Request for examination |
St.27 status event code: A-1-2-D10-D11-exm-PA0201 |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
St.27 status event code: A-1-2-D10-D21-exm-PE0902 |
|
| T11-X000 | Administrative time limit extension requested |
St.27 status event code: U-3-3-T10-T11-oth-X000 |
|
| T11-X000 | Administrative time limit extension requested |
St.27 status event code: U-3-3-T10-T11-oth-X000 |
|
| E13-X000 | Pre-grant limitation requested |
St.27 status event code: A-2-3-E10-E13-lim-X000 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| P20-X000 | Errors in documents filed by the applicant or ip right owner corrected |
St.27 status event code: A-2-2-P10-P20-nap-X000 |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
St.27 status event code: A-1-2-D10-D21-exm-PE0902 |
|
| T11-X000 | Administrative time limit extension requested |
St.27 status event code: U-3-3-T10-T11-oth-X000 |
|
| R18-X000 | Changes to party contact information recorded |
St.27 status event code: A-3-3-R10-R18-oth-X000 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| E701 | Decision to grant or registration of patent right | ||
| PE0701 | Decision of registration |
St.27 status event code: A-1-2-D10-D22-exm-PE0701 |
|
| GRNT | Written decision to grant | ||
| PR0701 | Registration of establishment |
St.27 status event code: A-2-4-F10-F11-exm-PR0701 |
|
| PR1002 | Payment of registration fee |
St.27 status event code: A-2-2-U10-U12-oth-PR1002 Fee payment year number: 1 |
|
| PG1601 | Publication of registration |
St.27 status event code: A-4-4-Q10-Q13-nap-PG1601 |
|
| LAPS | Lapse due to unpaid annual fee | ||
| PC1903 | Unpaid annual fee |
St.27 status event code: A-4-4-U10-U13-oth-PC1903 Not in force date: 20100522 Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE |
|
| PC1903 | Unpaid annual fee |
St.27 status event code: N-4-6-H10-H13-oth-PC1903 Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE Not in force date: 20100522 |